Just recently, a publication highlighted that a pill that combines several compositions of drugs had higher chances of reducing risks of cardiovascular diseases at presumably affordable costs that every individual would be comfortable with. UW-Madison school of medicine and public health conducted a research study which has been published in the January issue of Health Affairs. This was confirmed in a recent news release by UW.

About the objectives of the research study

The primary role of the study was to showcase the role this multi-drug pill would play towards limiting cardiovascular related conditions. The polypill would be a combination of aspirin, which is a statin that would aid in lowering cholesterol in blood, as well as three medications for blood pressure.

In the study findings, it was adversely reported that the pill would have positive impact on both men and women by reducing cardiovascular diseases by 21 and 15 percent respectively. These research findings were based on a lifetime offer and the head of the research program Dr. Leonelo Bautista together with his team, which was primarily made up of academicians as well as randomly selected public health officials from South America, the Caribbean as well as Central America.

In all, the study did not incorporate experts from North America because polypills are not authorized for production or sale within this region thus why it involved the Latin American countries instead. This information was confirmed from the release. According to Bautista in the release, he added that the type of intervention would not only be cost effective, but also cost saving meaning the economically challenged victims would have higher chances of securing medical help.

The research findings and its benefits

Although polypills are still not available in the US, it was evident that the research study had a positive impact and if they were allowed to be sold or manufactured in the country, lives would be saved. The point is that for men who are 55 years old or more had a higher chance to access drugs at lower costs, which would culminate to increased health benefits when compared to the standard approach normally taken during screening and treating of hypertensive as well as hypercholesterolemia victims.

The US has been described as one of the richest countries in the world that still lags behind towards fighting health problems that could lead to dangerous diseases such as heart failure or kidney problems. But their efforts to find out more about these conditions have not been challenged as they are publishing new methods to make life easier every day. Overall, whether you are a heart victim or a kidney victim, you want to ensure that your government’s intervention towards eradicating the condition is also a favor to you thus why the polypill can be a world savior if more studies were conducted on the same.